Delivering cytoprotective proteins/peptides into pancreata prior to islet isolation through protein transduction (PT) is a novel strategy to enhance the yield of viable transplantable islets. Previous work has shown that the protein transduction domain PTD-5 efficiently transduced islets via the pancreatic duct. TAT/PTD is a well-characterized PTD with the capability to cross even the hemato-encephalic barrier. In this study, we investigated the utilization of the 11-aa TAT protein transduction domain (TAT/PTD) to deliver peptides or proteins of different sizes ranging from 1.2 to 120 kDa, as the TAT/PTD and TAT/PTD-BH4 peptide, or the TAT/PTD-β-galactosidase fusion protein, into islets through the pancreatic duct. Using flow cytometry analysis we found that TAT/PTD derivatives transduced practically 100% of the islet cell population. Moreover, confocal laser scanning microscopy in live, nonfixed islets confirmed these results assessing transduction of TAT/PTD molecules into intact nondisaggregated islets. TAT-β-galactosidase peptide conjugated to FITC was not compartment selective, as both cytoplasmic and nucleic cellular compartments were positively stained. Furthermore, TAT-β-galactosidase peptide delivery was highly effective, as even cells located in the inner core region of the islets were transduced. Finally, transduced TAT-β-galactosidase fusion protein was biologically active after islet isolation and manipulation, and islet insulin secretion capability was not compromised by peptide transduction. These findings suggest that the transduction of chimeric TAT/PTD proteins can represent an efficient tool of molecular delivery independent of the size, to enhance or modify a specific phenotype at the nuclei or cytoplasmic level.
INTRODUCTION
sity of Wisconsin solution at the time of organ procurement enhanced viability of islets (16). A novel strategy proposed recently focused on peptide delivery by protein Since the development of new immunosuppressive regimens (18) most patients achieve long-term insulin transduction (PT) via the pancreatic duct (13). PT is based on utilization of protein transduction domains independence following islet transplantation. Viability and quality of transplantable pancreatic islets greatly in-(PTDs) (20) , small cationic peptides with the ability to translocate inside of the cell, to bring in cargo peptides fluence the outcome of the transplant. A great obstacle to successful islet transplantation is the recovery of sub-and proteins. In particular, in situ pancreatic duct infusion of PTD-5, a cationic peptide selected from an M13 optimal numbers of damaged islets after the isolation procedure. During the isolation procedure islets are ex-phage display library (10), efficiently transduced up to 40% of beta cells. Furthermore, delivery of the nuclear posed to enzymatic and mechanical stresses that result in apoptosis-and necrosis-induced cell death (12). More-factor kappa B inhibitor NBD peptide fused to PTD-5 preceding islet isolation yielded islets with enhanced over, islets are separated from their extracellular matrix, which provides them with survival signals (19) . viability (13). Proteins/peptides fused to PTDs or having the PTD Developing technologies for the delivery of cytoprotective reagents/molecules to the pancreas before islet naturally in their structure (11) can be delivered successfully into a large number of cells and tissues (9) , includ-isolation is becoming a strategy to maximize the recovery of viable islets for transplantation. The pancreatic ing pancreatic islets (2,3,10,11). One of the most characterized PTD is TAT/PTD, an 11-amino acid (aa) peptide duct has been utilized previously for the delivery of cytoprotective agents to the pancreas prior to islet isola-derived from basic domain of TAT/HIV transactivator protein (6, 5, 17) . In addition to peptide delivery, a large tion. For example, intraductal infusion of cold Univer-gamut of TAT/PTD-fused full-length functional proteins FBS and the cells washed in PBS. One million dissociated pancreatic islet cells were evaluated by flow cytom-has been transduced (21) in vitro and in vivo into cells, tissues, and even into brain cells crossing the hemato-etry for the expression of fluorescence. encephalic barrier (17) . TAT/PTD-based protein trans-Laser Scanning Confocal Microscopy. Whole islets duction technology is also being used for the developwere resuspended in PBS containing 0.5% BSA and ment of bioartificial organs (8, 23) . In this study, we plated on a glass bottom number 0 uncoated, γ-irradiated investigated the use of TAT/PTD transduction technolpetri dish (MatTek Corp., Ashland, MA) for confocal ogy to deliver protein/peptides to islets by ex vivo infumicroscopy. Propidium iodide (PI; 40 µl of a 0.5 mg/ml sion into the pancreatic duct. stock solution) was added to the cells before analysis to rule out internalization of the TAT-fused protein due to MATERIALS AND METHODS damaged cell membrane. The samples were examined under a Zeiss confocal laser scanning microscope LSM-510. Generation, Purification, and Labeling of TAT/PTD Derivatives β-Galactosidase Activity. Islets were washed in PBS and dissociated. After 5-min cytospin at 1000 rpm on HPLC-purified FITC-GYGRKKRRQRRR was syn-Histogrip-treated slides (Zymed, San Francisco, CA), thesized by Sigma/Genosys (St. Louis, MO), yielding cells were air dried for 15 min and then stained using 98% purity of the labeled peptide. TAT/PTD-β-galactosthe β-Gal staining kit (Stratagen, La Jolla, CA) followidase was purified as described previously (3) period, samples were collected and the low-glucose Pancreatic Duct Infusion. C57BL/6 mice were sacribuffer was replaced with Krebs high-glucose buffer (400 ficed and the abdomen opened. TAT/PTD-FITC or mg/dl) and columns were incubated for 1 h as before. TAT/PTD-β-galactosidase-Alexa-Fluor-488 (200 µl of The high-glucose buffer was collected and replaced 1 mM or 300 µl of 1 mg/ml stock in PBS, respectively) again with low-glucose buffer and collected after anor PBS was retrogradely injected in the pancreas by canother 1-h incubation. Insulin content was determined nulation of the common bile duct, after having clamped with the Insulin Elisa kit (Alpko, Winham, NH). its entrance to the duodenum, followed immediately with collagenase distention.
RESULTS

Islet Isolation. A 0.8 mg/ml collagenase (type V;
Pancreatic Ductal Delivery of TAT/PTD Sigma) solution prepared in Hanks' balanced salt solu-Derivatives and Flow Cytometry and Laser tion (HBSS; Mediatech, Herndon, VA) was injected ret-Scanning Microscopy Assessment rogradely via the main bile duct until full distension of
We investigated transduction and endurance of prothe pancreas was achieved. The pancreatic tissue was tein and peptides fused to TAT/PTD protein in islet surgically removed, collected in collagenase solution, cells, following the mechanical and enzymatic stresses and then digested and purified as described previously (1) .
of the islet isolation procedure. For this purpose, TAT/ PTD and TAT/PTD-β-galactosidase (representing mol-Assessment of Protein and Peptide Transduction ecules ranging from 1.2 to 120 kDa) were labeled with FITC (green) or Alexa-Fluor-568 (red), respectively, Flow Cytometry. Islets obtained after ex vivo pancreas transduction were washed in PBS and dissociated and infused into the pancreas via the pancreatic duct prior to islet isolation. After TAT/PTD infusion and dis-into a single cell suspension by a 4-min continuous pipetting in HBSS containing 0.5% trypsin and 0.53 mM tention with collagenase, islets were isolated, dissociated, and evaluated by flow cytometry. The shift of islet EDTA. The enzymatic reaction was stopped with 100% cell fluorescence profiles confirmed that TAT/PTD-ery of TAT-BH4, a peptide comprising conserved homology region 4 (BH4) domain from Bcl-XL fused to FITC was present in almost 100% of the islet cell population ( Fig. 1A ). Cells transduced with TAT/PTD-FITC TAT/PTD. We found that transduced islets maintained their ability to secrete insulin physiologically in a simi-had median fluorescence intensities (MFI) of 213% when compared with control cells. lar way as control nontransduced islets (Fig. 4A) , similar to what we previously observed in transduction of islets Notably, flow cytometry analysis does not discriminate between cell membrane-bound or internal fluores-in vitro with TAT fusion proteins (3, 14) . We also investigated whether pancreatic duct-trans-cence. Therefore, we also examined live (nonfixed) nondissociated islets by confocal microscopy. This analysis duced proteins retained full biological activity, as shown by β-galactosidase staining of islet cells with X-gal. (Fig. 1B) showed that TAT/PTD-FITC was able to transduce the islets throughout, as most of the fluores-Islets freshly isolated and fully transduced with TAT-βgalactosidase-Alexa-Fluor-488 had a strong β-galactosicence was detected through the entire stack of optical sections, including the inner core region of islets.
dase staining (Fig. 4B ). This result suggests that TAT-βgalactosidase transduced ex vivo efficiently folded into its To investigate transduction of TAT/PTD fusion proteins into islet cells, via the pancreatic duct, we infused biologically active tetramer form in the host cells (7) . TAT-β-galactosidase labeled with the fluorescent dye DISCUSSION Alexa-Fluor-488 (green fluorescence). Similar to islets infused with TAT/PTD, confocal microscopy analysis of
The fluorescence profile of islets isolated after pancreatic duct infusion of TAT/PTD-FITC indicates that live islets transduced with TAT-β-galactosidase showed that the fluorescence was present through the entire every single cell from the dissociated islets was more fluorescent than the control islet as assessed by flow cy-stack of optical sections ( Fig. 2A ). In this particular experiment, islets were stained with PI to rule out the pos-tometry (Fig. 1A) . Because cell-penetrating peptides have a tendency to cross membranes in both directions, sibility of TAT-β-galactosidase internalization due to damaged cell membrane. The vast majority of green flu-and therefore wash out from live cells (4), it is important to emphasize that the differences of MFI observed be-orescence was not colocalized with PI staining, suggesting that cells were transduced by the fusion protein.
tween control and transduced islets (213%) could be much higher. Indeed, fluorescence is washed out during To confirm TAT-β-galactosidase transduction of islets, we infused TAT-β-galactosidase labeled with the enzymatic treatment and washes utilized for islet cell dissociation. Previous studies have shown that intraduc-fluorescent dye Alexa-Fluor-568 (rhodamine-like fluorescence) via the pancreatic duct of transgenic mice ex-tal delivery of the protein transduction domain PTD-5 transduced 30-40% of beta cells (13), while in the pres-pressing the fluorescent GFP protein under the control of the actin promoter ( Fig. 2B ). After isolation nondisso-ent study TAT/PTD almost transduced 100% of islets cells. This difference in the percentage of transduced ciated live islets were analyzed using confocal laser scanning microscopy. We observed colocalization of cells could be due to a higher efficiency of transduction for TAT/PTD or alternatively it could be due to a differ-green fluorescence, generated by the endogenous GFP expression of islet cells with labeled TAT-β-galactosi-ence in wash out from cells of either PTD. In addition, we analyzed the transduced islets with dase-Alexa-Fluor-568 ( Fig. 2B) , which unequivocally indicates the presence of the TAT/PTD-fused protein in-confocal laser scanning microscopy. We observed FITC fluorescence throughout almost every islet, reaching side of the islet cells. In addition, we analyzed six optical sections, numbers 35 to 40, taken from the middle even cells located in the most inner core of the islets (Fig. 2) . To analyze the transduction of islet by pancre-of 95 optical sections stack. We observed colocalization of TAT-β-galactosidase in every GFP-producing cell (or-atic ductal infusion of a large protein, we delivered TAT-β-galactosidase labeled with Alexa 568 into the ange dots). TAT-β-galactosidase was also present in cells that produced a minimal amount of GFP (red dots) pancreatic duct of a GFP transgenic mouse in which the transcription of green fluorescent protein GFP was driven (Fig. 3A) . Furthermore, TAT-β-galactosidase was present in the cytoplasm as well as in the nuclei, as shown by the actin promoter. We found a colocalization of green fluorescent GFP-expressing cells with Alexa-568-labeled in Figure 3B .
TAT-β-galactosidase, indicating presence of this TAT/ Transduction Through Pancreatic Duct PTD fusion protein inside of the islet cells. Moreover,
Does Not Affect Islet Function
TAT-β-galactosidase was localized in the cytoplasm as well as in the nuclei (Fig. 3B ). This is an important fea-To investigate whether the pancreatic ductal delivery of TAT/PTD derivatives affects the insulin secretion ca-ture of the TAT/PTD system because it could allow delivery of cytoplasmic and nuclear proteins/peptides. The pability of islets, we performed static glucose challenge stimulation in islets isolated after pancreatic duct deliv-punctuated fluorescence pattern observed within the is- lets suggests that the labeled molecules were localized their insulin secretion capability, a key requirement for the application of this technology (Fig. 4A ). in cytoplasmic endocytic vesicles, in agreement with previous reports (15, 22) . Subsequent release of TAT/PTD Finally, the results shown in Figure 4B suggest that TAT-β-galactosidase remained active and properly fol-fusion proteins from endosomic vesicles to the cytoplasm has been postulated (22) , allowing the transduced mole-ded once transduced into islets, as assessed by measurement of β-galactosidase enzymatic activity. Although cule to exert its biological function.
As we expected, TAT/PTD fusion protein transduc-some of the β-galactosidase activity could be due to TAT-β-galactosidase sticking to the membrane, this is tion of islets via the pancreatic duct did not compromise unlikely because islet cells were dissociated and treated TAT delivery system could be particularly useful when the expression of a given gene is only transiently with trypsin previous to X-gal staining.
All together our results indicate that TAT/PTD and needed, as it often happens with antiapoptotic genes. In addition, it offers the advantage of a quick response, as even large proteins such as β-galactosidase when coupled with TAT/PTD can be delivered through the pan-shown by β-galactosidase activity in freshly isolated islets, which differs considerably from the time required creatic duct to practically 100% of islet cells, without affecting the islet insulin secretion capability and the bi-for expression of genes delivered to islets (from 24 to 72 h). ological activity. Islets isolated from nontransduced control and TAT-BH4-treated pancreata were cultured for 36 h before being harvested for the static glucose challenge test. The experiment shown is representative of three independent experiments performed by duplicates with islets isolated from a pool of animals. Values are expressed as means ± SD. L1: low glucose, H: high glucose, L2: second low-glucose incubation, SI: stimulation index. (B) β-Galactosidase activity in transduced islets. Freshly isolated islets obtained from control (left) and from TAT-β-galactosidase-Alexa-Fluor-488-infused mice (right) were dissociated, spread on the slide uniformly using cytospin, and then stained by X-gal to ascertain β-galactosidase activity. The data shown in (B) suggest that intraductal injection of TAT-β-galactosidase-Alexa-Fluor-488 prior to islet isolation results in efficient transduction of islet cells, and that the transduced protein retains its activity in the transduced cells. 
